Promoter collection, Human PGR promoter
Alternative name | U3063-9 |
---|---|
Clone info. | PCR amplified human PGR promoter sequence was inserted into a firefly luciferase vector. Cloned fragment: 101131251 to 101129781(NC_000011.10); relatively -2188 to -717, where +1 corresponds to 1 nt of NM_001202474.3; relatively -1438 to +33, where +1 corresponds to 1 nt of NM_000926.4. |
Comment | PCR cloning, forward primer: aatagtgctgatggttgcaca; reverse primer: aaggcttaccccgattagtga. Entire sequence of promoter region has not been confirmed. |
Vector backbone | pGL4.10 [Luc2] (Plasmid) |
Selectable markers | Amp^r |
Gene/insert name | Human progesterone receptor genomic DNA |
Depositor|Developer | DNA Bank, | |
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ] MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ] Please visit Information of Request for Distribution.[link] |
---|---|
Terms and conditions for distribution | In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. Additional terms and conditions: The use of the BIOLOGICAL RESOURCE is restricted to the academic researches conducted by non-profit organization. By using this material, the RECIPIENT agrees to be bound by the conditions of the limited use statement of the Promega Corporation. |
必要書類 | 提供依頼書 [依頼書の記入例 ] 提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ] 手続きの概要は、「提供申込みについて[link]」をご覧ください。 |
---|---|
MTAに書く使用条件 | 謝辞の表明を必要とする。 MTAに書く付加的使用条件: 本件リソースの使用は学術機関での学術研究に限る。本件リソースの使用にあたって、利用者はプロメガ社の限定使用条件に従う必要がある。 |
Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
---|---|---|---|
RDB07809 | pGL4-phPGR | DNA solution |
Materials & Methods section:
The pGL4-phPGR was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB07809). |
Reference section:
Further references such as user reports and related articles (go to bottom)
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB07809_A5A6.pdf |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: pGL4-4174F Sequence file: RDB07809_A5A6a.seq |
---|
>07809_07809_A5A6_3_pGL4-4174F_E01_13.ab1 1 GATGGGTCAG ACTTTCTCTG GCTACTGGCC GGTACCTGAG CTCGCTAGCC TCGAGGATAA 61 TAGTGCTGAT GGTTGCACAA CTCTGAGTAC ATGAAAAATC AATGAACTGA TACTTTGAGT 121 GAGCTGTATG ATACTGGAAT TACACCTCAA TAAAGCATGG TAACTGTTTT AAGATAGGCT 181 GGAAAGAGAA AGCCTGAAAA CAACAATAAT GATATTAATA AATTAGTTTA CTTCTCTAGT 241 CTCATATACT TCTGTGCCCA CACTTGCTCC TGTTCTATTC ATAATGGTCC CCTTGCAGTT 301 GCCATATTAT ATCCTGCCAT TTGATGCCCG GTGAACATTC TATACCTGCT TCCCAGAATT 361 CTCTTTACCT TTCCTCTATC TGCCTAACTT CCACATATCT AAAATTAATC AGAGTAAACT 421 ATTTACTAGA ACAACCAACT CCAAATCCTA GTAACCTAAC ATGATAAAGG TTTGTTTCTC 481 ACTCATATAG CCCCTCCCCA GATGATCGAG GGGTCCAGGC TCCTTACCTC TAGTGGCTCC 541 CCCACCTTCT GGAGTCTTCT GCATTCTTTA TACATGGTTG AGATAAACTA TGAGTCATTA 601 GCACAGCTAG ACCTTGAGGT CCTACAAGAA AATTTGCAAA TCATTCACTC TGTTTTGAAC 661 AAGGTATATT TAAGATGATG TTAAAATACC CAATGGTCTT GGGTCAAATA CAGTTTATGA 721 CTGTGTATCT AAAATATATA TTGCAATATT CTTCCCTTTT TCTACTGACT TCATGAATTT 781 AGCGGGGATC CATTTTATAA GCTCAAAGAT AATTACTTTT CAGACTAAGA ATATTTAGGG 841 TAAAAAGTAC TGTTCAACAT CTCTACTGAG GATGTTATGA TGTAGCACAC TGTATAAGCT 901 GGAGCTAAAG GAAACTTTCC TTAAAGTGCT ATTTACTAAA AATTGGAACA CATTCCTTAA 961 GACAAATCGA AGTGTGGCAC ACAACATCCA AACTTCCATC ATAGATACAG AGGTGTTACC 1021 ATCTCCCACT CCCAAATTTC TTTGTCACGC TGAGGATACT CAAGAGGAGC AGACATGGTT 1081 GGGTCGGCAG CAAGGAGAAC CTGCAAGGCC AATTCACTTT TTATGGAACT CAATAAAGGG 1141 GGGAGAGAGA GAAATTCGTC T // |
Primer: pGL4-136R Sequence file: RDB07809_A5A6b.seq |
>07809_07809_A5A6_3_pGL4-136R_F01_16.ab1 1 GGATCTAGGT TTGGCATCTT CCATGGTGGC TTTACCAACA GTACCGGATT GCCAAGCTTG 61 GCCGCCGAGG CCAGATCTTG ATAAGGCTTA CCCCGATTAG TGACAGCTGT GGACTGGCCA 121 GACAGCTTTC TAACAACGCC TCCTCCTCTA GGGAGGCCCC GCCCAAAGCC CCTCCCTACC 181 CCAATTACCG GTAGGATCTG AAACTCTGGA GTTGGCATTT CCACCCGTTA TTCTGAATGC 241 TACTCTCAAT AGCAGGTTCT TTGGGATGGA ACCTCATAAG CATATTACGT TTTGTTTTGC 301 AAATTAAGAA TTATGCCCTA TCTAATTGGA AAAATGAATA GATTCTATCA GAAGTAGAAT 361 TTTTGTCACC ATTTTAAGAT TTCAGTTTTG TAAAGATTTA ACACAGAGGA AGACATTTGG 421 CTACATTATC TTTTAAAATA ATAAATGTAT CAAGGACGAT ACTAAATAAG AGATTCTCTC 481 CCTTATGAGT TCCATAAAAG TGAATGCTTT CAAGTTTCTC CTGCTGCGAC CAACATGTCC 541 TGCTCCTCTT GAGTATCCTC AGCGTGACAA AGAAATTTGG GAGTGGGAGA TGGTAACACC 601 TCTGTATCTA TGATGGAAGT TTGGATGTTG TGTGCCACAC TTCGATTTGT CTTAAGGAAT 661 GTGTTCCAAT TTTTAGTAAA TAGCACTTTA AGGAAAGTTT CCTTTAGCTC CAGCTTATAC 721 AGTGTGCTAC ATCATAACAT CCTCAGTAGA GATGTTGAAC AGTACTTTTT ACCCTAAATA 781 TTCTTAGTCT GAAAAGTAAT TATCTTTGAG CTTATAAAAT GGATCCCCGC TAAATTCATG 841 AAGTCAGTAG AAAAAGGGAA GAATATTGCA ATATATATTT TAGATACACA GTCATAAACT 901 GTATTTGACC CAAGACCATT GGGTATTTTA ACATCATCTT AAATATACCT TGTTCAAAAC 961 AGAGTGAATG ATTTGCAAAT TTTCTTGTAG GACCTCAAGG TCTAGCTGTG CTAATGACTC 1021 ATAGTTTATC TCAACCCATG TATAAGAATG CAGAAGACTC CCAGAATGTG GGGGGAGCAC 1081 TAGAGGGTAA GGAGTCTGAC TCCTCGATCA TCTGGGGAAG GGGCCTATAT GGAATGAAAT 1141 CCAAGCTTTC ATCCAATGGG T // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
Featured content